U
Adaptimmune Therapeutics plc ADAPY
$0.04 $0.003.86% OTC PK
Recommendation
Dividend Power Score
Prev Close
--
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
--
Corporate Info
Phone Number
--
Address
The Innovation Centre
99 Park Drive, Milton Park
Abingdon, OX14 4RY
Country
United Kingdom
Year Founded
2008
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
506
Business Description
Adaptimmune Therapeutics plc engages in research, development, and subsequent manufacture and commercialisation of cell therapies to treat cancer in the United States and the United Kingdom. The company was founded in 2008 and is headquartered in Abingdon, the United Kingdom.